ARCHIVES

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 13 | April 4, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

Letter to the Editor: A Victory for Research, But Real Work Is Ahead

November 26, 1999

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003